Different miRNA expression profiles between human breast cancer tumors and serum

Frontiers in Genetics

Volumn 5, Issue MAY, 2014, Pages

  Zhu, Jie ^a   Zheng, Zhibao ^a   Wang, Jia ^b   Sun, Jinhua ^c   Wang, Pan ^a   Cheng, Xianying ^c   Fu, Lun ^d   Zhang, Liming ^a   Wang, Zuojun ^a   Li, Zhaoyun ^a,d  

^a TAIZHOU CENTRAL HOSPITAL   (China)

^b Radiation Therapy Department   (China)

^c JoinGenome Bioinformatics Company   (China)

^d WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Breast cancer; Mirna; Serum; Tumor

Indexed keywords

EID: 84905640869     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00149     Document Type: Article

References (50)

1. Anaya-Ruiz, M., Bandala, C., and Perez-Santos, J. L. (2013). miR-485 acts as a tumor suppressor by inhibiting cell growth and migration in breast carcinoma T47D cells. Asian Pac. J. Cancer Prev. 14, 3757-3760. doi: 10.7314/APJCP.2013.14.6.3757
2. Asli, N. S., Pitulescu, M. E., and Kessel, M. (2008). MicroRNAs in organogenesis and disease. Curr. Mol. Med. 8, 698-710. doi: 10.2174/156652408786733739
3. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297. doi: 10.1016/S0092-8674(04)00045-5
4. Blondal, T., Jensby Nielsen, S., Baker, A., Andreasen, D., Mouritzen, P., Wrang Teilum, M., et al. (2013). Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 59, S1-S6. doi: 10.1016/j.ymeth.2012.09.015
5. Brase, J. C., Wuttig, D., Kuner, R., and Sultmann, H. (2010). Serum microRNAs as non-invasive biomarkers for cancer. Mol. Cancer 9:306. doi: 10.1186/1476-4598-9-306
6. Carrington, J. C., and Ambros, V. (2003). Role of microRNAs in plant and animal development. Science 301, 336-338. doi: 10.1126/science.1085242
7. Chan, M., Liaw, C. S., Ji, S. M., Tan, H. H., Wong, C. Y., Thike, A. A., et al. (2013). Identification of circulating microRNA signatures for breast cancer detection. Clin. Cancer Res. 19, 4477-4487. doi: 10.1158/1078-0432.CCR-12-3401
8. Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., et al. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006. doi: 10.1038/cr.2008.282
9. Cuk, K., Zucknick, M., Heil, J., Madhavan, D., Schott, S., Turchinovich, A., et al. (2013). Circulating microRNAs in plasma as early detection markers for breast cancer. Int. J. Cancer 132, 1602-1612. doi: 10.1002/ijc.27799
10. Desantis, C., Ma, J., Bryan, L., and Jemal, A. (2014). Breast cancer statistics, 2013. CA Cancer J. Clin. 64, 52-62. doi: 10.3322/caac.21203
11. Dhahbi, J. M., Atamna, H., Boffelli, D., Magis, W., Spindler, S. R., and Martin, D. I. (2011). Deep sequencing reveals novel microRNAs and regulation of microRNA expression during cell senescence. PLoS ONE 6:e20509. doi: 10.1371/journal.pone.0020509
12. Duttagupta, R., Jiang, R., Gollub, J., Getts, R. C., and Jones, K. W. (2011). Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS ONE 6:e20769. doi: 10.1371/journal.pone.0020769
13. Griffiths-Jones, S. (2010). miRBase: microRNA sequences and annotation. Curr Protoc Bioinformatics Chapter 12, Unit 12.9.1-10. doi: 10.1002/0471250953.bi1209s29
14. Huang, J., Hao, P., Chen, H., Hu, W., Yan, Q., Liu, F., et al. (2009). Genome-wide identification of Schistosoma japonicum microRNAs using a deep-sequencing approach. PLoS ONE 4:e8206. doi: 10.1371/journal.pone.0008206
15. Huang, L., Dai, T., Lin, X., Zhao, X., Chen, X., Wang, C., et al. (2012). MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochem. Biophys. Res. Commun. 425, 127-133. doi: 10.1016/j.bbrc.2012.07.025
16. Huang Da, W., Sherman, B. T., and Lempicki, R. A. (2009a). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13. doi: 10.1093/nar/gkn923
17. Huang Da, W., Sherman, B. T., and Lempicki, R. A. (2009b). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57. doi: 10.1038/nprot.2008.211
18. Jiang, Q., Wang, Y., Hao, Y., Juan, L., Teng, M., Zhang, X., et al. (2009). miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res. 37, D98-D104. doi: 10.1093/nar/gkn714
19. Ke, X. S., Liu, C. M., Liu, D. P., and Liang, C. C. (2003). MicroRNAs: key participants in gene regulatory networks. Curr. Opin. Chem. Biol. 7, 516-523. doi: 10.1016/S1367-5931(03)00075-9
20. Kozomara, A., and Griffiths-Jones, S. (2014). miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 42, D68-D73. doi: 10.1093/nar/gkt1181
21. Langmead, B., Trapnell, C., Pop, M., and Salzberg, S. L. (2009). Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10:R25. doi: 10.1186/gb-2009-10-3-r25
22. Li, B., Chu, X., Gao, M., and Xu, Y. (2011). The effects of CD59 gene as a target gene on breast cancer cells. Cell. Immunol. 272, 61-70. doi: 10.1016/j.cellimm.2011.09.006
23. Li, M., Xia, Y., Gu, Y., Zhang, K., Lang, Q., Chen, L., et al. (2010). MicroRNAome of porcine pre- and postnatal development. PLoS ONE 5:e11541. doi: 10.1371/journal.pone.0011541
24. Li, S., Meng, H., Zhou, F., Zhai, L., Zhang, L., Gu, F., et al. (2013). MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol. Res. Pract. 209, 179-183. doi: 10.1016/j.prp.2012.12.002
25. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834-838. doi: 10.1038/nature03702
26. Lu, Y. C., Smielewska, M., Palakodeti, D., Lovci, M. T., Aigner, S., Yeo, G. W., et al. (2009). Deep sequencing identifies new and regulated microRNAs in Schmidtea mediterranea. RNA 15, 1483-1491. doi: 10.1261/rna.1702009
27. Madjd, Z., Pinder, S. E., Paish, C., Ellis, I. O., Carmichael, J., and Durrant, L. G. (2003). Loss of CD59 expression in breast tumours correlates with poor survival. J. Pathol. 200, 633-639. doi: 10.1002/path.1357
28. Mar-Aguilar, F., Luna-Aguirre, C. M., Moreno-Rocha, J. C., Araiza-Chavez, J., Trevino, V., Rodriguez-Padilla, C., et al. (2013a). Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. Asia Pac. J. Clin. Oncol. 9, 53-59. doi: 10.1111/j.1743-7563.2012.01548.x
29. Mar-Aguilar, F., Mendoza-Ramirez, J. A., Malagon-Santiago, I., Espino-Silva, P. K., Santuario-Facio, S. K., Ruiz-Flores, P., et al. (2013b). Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Dis. Markers 34, 163-169. doi: 10.3233/DMA-120957
30. Mcdermott, A. M., Miller, N., Wall, D., Martyn, L. M., Ball, G., Sweeney, K. J., et al. (2014). Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer. PLoS ONE 9:e87032. doi: 10.1371/journal.pone.0087032
31. Meri, S., Morgan, B. P., Davies, A., Daniels, R. H., Olavesen, M. G., Waldmann, H., et al. (1990). Human protectin (CD59), an 18,000-20,000 mW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71, 1-9.
32. Ng, E. K., Li, R., Shin, V. Y., Jin, H. C., Leung, C. P., Ma, E. S., et al. (2013). Circulating microRNAs as specific biomarkers for breast cancer detection. PLoS ONE 8:e53141. doi: 10.1371/journal.pone.0053141
33. Palma, J., Yaddanapudi, S. C., Pigati, L., Havens, M. A., Jeong, S., Weiner, G. A., et al. (2012). MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res. 40, 9125-9138. doi: 10.1093/nar/gks656
34. Pescador, N., Perez-Barba, M., Ibarra, J. M., Corbaton, A., Martinez-Larrad, M. T., and Serrano-Rios, M. (2013). Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers. PLoS ONE 8:e77251. doi: 10.1371/journal.pone.0077251
35. Pigati, L., Yaddanapudi, S. C., Iyengar, R., Kim, D. J., Hearn, S. A., Danforth, D., et al. (2010). Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS ONE 5:e13515. doi: 10.1371/journal.pone.0013515
36. Pritchard, C. C., Kroh, E., Wood, B., Arroyo, J. D., Dougherty, K. J., Miyaji, M. M., et al. (2012). Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev. Res. (Phila.) 5, 492-497. doi: 10.1158/1940-6207.CAPR-11-0370
37. Ryu, S., Joshi, N., Mcdonnell, K., Woo, J., Choi, H., Gao, D., et al. (2011). Discovery of novel human breast cancer microRNAs from deep sequencing data by analysis of pri-microRNA secondary structures. PLoS ONE 6:e16403. doi: 10.1371/journal.pone.0016403
38. Schotte, D., Akbari Moqadam, F., Lange-Turenhout, E. A., Chen, C., Van Ijcken, W. F., Pieters, R., et al. (2011). Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia. Leukemia 25, 1389-1399. doi: 10.1038/leu.2011.105
39. Schrauder, M. G., Strick, R., Schulz-Wendtland, R., Strissel, P. L., Kahmann, L., Loehberg, C. R., et al. (2012). Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS ONE 7:e29770. doi: 10.1371/journal.pone.0029770
40. Siegel, R., Ma, J., Zou, Z., and Jemal, A. (2014). Cancer statistics, 2014. CA Cancer J. Clin. 64, 9-29. doi: 10.3322/caac.21208
41. Tarazona, S., García, F., Ferrer, A., Dopazo, J., and Conesa, A. (2012). NOIseq: a RNA-seq differential expression method robust for sequencing depth biases. EMBnet. J. 17, 18-19. doi: 10.14806/ej.17.B.265
42. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., and Lotvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659. doi: 10.1038/ncb1596
43. Valenti, R., Huber, V., Iero, M., Filipazzi, P., Parmiani, G., and Rivoltini, L. (2007). Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res. 67, 2912-2915. doi: 10.1158/0008-5472.CAN-07-0520
44. Walter, B. A., Valera, V. A., Pinto, P. A., and Merino, M. J. (2013). Comprehensive microRNA profiling of prostate cancer. J. Cancer 4, 350-357. doi: 10.7150/jca.6394
45. Wei, Q., He, W., Yao, J., Guo, L., Lu, Y., and Cao, X. (2013). Identification and characterization of microRNAs expressed in human breast cancer T-47D cells in response to prolactin treatment by Solexa deep-sequencing technology. Biochem. Biophys. Res. Commun. 432, 480-487. doi: 10.1016/j.bbrc.2013.02.016
46. Xiao, F., Zuo, Z., Cai, G., Kang, S., Gao, X., and Li, T. (2009). miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 37, D105-D110. doi: 10.1093/nar/gkn851
47. Yang, S., Li, Y., Gao, J., Zhang, T., Li, S., Luo, A., et al. (2013). MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene 32, 4294-4303. doi: 10.1038/onc.2012.432
48. Zhang, Y., Yan, L. X., Wu, Q. N., Du, Z. M., Chen, J., Liao, D. Z., et al. (2011). miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res. 71, 3552-3562. doi: 10.1158/0008-5472.CAN-10-2435
49. Zhao, B. S., Liu, S. G., Wang, T. Y., Ji, Y. H., Qi, B., Tao, Y. P., et al. (2013). Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac. J. Cancer Prev. 14, 139-143. doi: 10.7314/APJCP.2013.14.1.139
50. Zhao, Y., and Srivastava, D. (2007). A developmental view of microRNA function. Trends Biochem. Sci. 32, 189-197. doi: 10.1016/j.tibs.2007.02.006